Bone abnormalities in gastrointestinal and hepatic disease

Current Opinion in Pediatrics

Volumn 11, Issue 5, 1999, Pages 402-407

  Sylvester, Francisco A ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b Farmington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DISEASE; BONE MASS; BONE MINERALIZATION; BONE REMODELING; CELIAC DISEASE; CHOLESTATIC HEPATITIS; DISEASE ASSOCIATION; ENTERITIS; GASTRECTOMY; GASTROINTESTINAL DISEASE; HEPATITIS C; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; OSTEOSCLEROSIS; PRIORITY JOURNAL; REVIEW;

BONE DISEASES, METABOLIC; CHILD; GASTROINTESTINAL DISEASES; HUMANS; LIVER DISEASES; OSTEOMALACIA; OSTEOPOROSIS;

EID: 0032852721     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199910000-00006     Document Type: Review

References (61)

1. Finkelstein JS, Neer RM, Biller BMK, Crawford JD, Klibanski A: Osteopenia in men with a history of delayed puberty. N Engl J Med 1992, 326:600-604.
2. Grampp S, Jergas M, Glüer CC, Lang P, Brastow P, Genant HK: Radiologic diagnosis of osteoporosis: current methods and perspectives. Radiol Clin North Am 1993, 31:1133-1145.
3. Herzog D, Bishop N, Glorieux F, Seidman EG: Interpretation of bone mineral density values in pediatric Crohn's disease. Inflamm Bowel Dis 1998,4:261-267. In this paper, these authors make the point that in children with Crohn's disease with delayed skeletal maturity, Z scores for DXA need to be adjusted to height age or bone age to have a more accurate assessment of bone mineral density. In these patients, calculations based solely on chronologic age may overestimate the prevalence of osteopenia.
4. Blake GM, Fogelman I: Application of bone densitometry for osteoporosis. Endocrinol Metab Clin North Am 1998, 27:267-288.
5. Glüer C-C, International Quantitative Ultrasound Consensus Group: Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. J Bone Mineral Res 1997, 12:1280-1286.
6. Rea F, Polito C, Iovene A, Pluvio R, Rea L, Piscitelli A, et al.: Effect of gluten-free diet on bone mineral metabolism of celiac children. Nutrition Res 1998, 18:1661-1666.
7. Kemppainen T, Kröger H, Janatuinen E, Arnala I, Kosma V-M, Pikkarainen P, et al.: Osteoporosis in adult patients with celiac disease. Bone 1999, 24:249-255.
8. Selby PL, Davies M, Adams JE, Mawer EB: Bone toss in celiac disease is related to secondary hyperparathyroidism. J Bone Miner Res 1999, 14:652-657.
9. Mora S, Barera G, Ricotti A, Weber G, Bianchi C, Chiumello G: Reversal of low bone density with a gluten-free diet in children and adolescents with celiac disease. Am J Clin Nutr 1998, 67:477-481.
10. Mazure R, Vazquez H, Gonzalez D, Mautalen C, Pedreira S, Boerr L, et al.: Bone mineral affection in asymptomatic adult patients with celiac disease. Am J Gastroenterol 1994, 89:2130-2134.
11. Molteni N, Caraceni MP, Bardella MT, Ortolani S, Gandolini GG, Bianchi P: Bone mineral density in adult celiac patients and the effect of gluten-free diet from childhood. Am J Gastroenterol 1990, 85:51-53.
12. Fomari MC, Pedreira S, Niveloni S, Gonzalez D, Diez RA, Vazquez H, et al.: Pre- and post-treatment serum levels of cytokines IL-1β, IL-6, and IL-1 receptor antagonist in caliac disease: are they related to the associated osteopenia? Am J Gastroenterol 1998, 93:413-418. The authors of this study determined bone mineral density by DXA, and measured serum cytokine levels in 16 women both at the time of the diagnosis of celiac disease and then at a mean of 37 months on gluten-free diet. Patients with Z scores of less than -2 had significantly lower interleukin-1 receptor antagonist concentrations that those with Z scores of greater than -2. Interleukin-6 levels were inversely correlated with baseline lumbar spine Z score (R = -0.61; P < 0.01). The authors suggest that cytokines might have a role in the osteopenia associated with celiac disease.
13. Mora S, Barera G, Beccio S, Proverbio MC, Weber C, Bianchi C, et al.: Bone density and bone metabolism are normal after long-term gluten-free diet in young celiac patients. Am J Gastroenterol 1999, 94:398-403. Bone density measured by DXA in lumbar spine and total body was compared between two groups: 1) 30 patients with celiac disease (age 21.9 y ± 4.4 y) on a strict gluten-free diet for a mean of 10.7 plus or minus 4.3 years (range, 5 y to 21 y) and 2) 240 healthy control subjects. In addition, intact parathyroid hormone, vitamin D levels, biochemical markers of bone formation (bone-specific alkaline phosphatase, N-terminal propeptide of type I procollagen in serum), and bone resorption (N-terminal telopeptide of type I collagen in urine) were also measured in these subjects. Bone mineral density in lumbar spine and total body, and all laboratory parameters tested, were not significantly different between celiac patients and control subjects after correction for confounding variables. Although these patients were not followed prospectively from the time of diagnosis, these data suggest that a strict gluten-free diet can reverse the decrease in bone mineral density associated with untreated celiac disease.
14. Fries W, Dinca M, Luisetto G, Peccolo F, Bottega F, Martin A: Calcaneal ultrasound bone densitometry in inflammatory bowel disease: a comparison with double x-ray densitometry of the lumbar spine. Am J Gastroenterol 1998, 93:2339-2344.
15. Robinson RJ, Carr I, Iqbal SJ, Al-Azzawi F, Abrams K, Mayberry JF: Screening for osteoporosis in Crohn's disease: a detailed evaluation of calcaneal ultrasound. Eur J Gastroenterol 1998, 10:137-140.
16. Schulte C, Dignass AU, Mann K, Goebell H: Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflammatory Bowel Dis 1998, 4:268-275.
17. Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS: Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998, 114:902-911. This is the most complete study to date on the effects of IBD on bone metabolism in children. It is a prospective study in 99 children with IBD and 63 healthy sibling control subjects, in which patients had an extensive clinical and laboratory evaluation and DXA to measure bone mineral density of the lumbar spine, femoral neck, and radius. Cumulative doses of corticosteroids were recorded. Bone mineral density Z scores were compared on the basis of bone age and pubertal stage in addition to chronologic age. Bone mineral density Z scores at the lumbar spine and femoral neck were lower in patients with IBD, and lower in those with Crohn's disease compared with those with ulcerative colitis. Low bone mineral density persisted after correction for bone age in girls with Crohn's disease. Cumulative corticosteroid dose was a predictor of low bone mineral density.
18. Ghosh S, Cowen S, Hannan WJ, Ferguson A: Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994, 107:1031-1039.
19. Jahnsen J, Falch JA, Aadland E, Mowinckel P: Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997, 40:313-319.
20. Angulo P, Therneau TM, Jorgensen RA, DeSotel CK, Egan KS, Dickson ER, et al.: Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J Hepatol 1998, 29:729-735.
21. Semeao EJ, Stallings VA, Peck SN, Piccoli DA: Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology 1997, 112:1710-1713.
22. Robinson RJ, Al Azzawi F, Iqbal SJ, Kryswcki T, Almond L, Abrams K, et al.: Osteoporosis and determinants of bone density in patients with Crohn's disease. Dig Dis Sci 1998, 43:2500-2506.
23. Boot AM, Bouquest J, Krenning EP, de Muinck Keizer-Schrama SMPF: Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 1998, 42:188-194.
24. Robinson RJ, Iqbal SJ, Al-Azzawi F, Abrams K, Mayberry JF: Sex hormone status and bone metabolism in men with Crohn's disease. Aliment Pharmacol Ther 1998, 12:21-25.
25. Andreassen H, Rix M, Brot C, Eskildsen P: Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease. Scand J Gastroenterol 1998, 33:1087-1093.
26. Motley RJ, Clements D, Evans WD, Crawley EO, Evans C, Rhodes J, et al.: A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner 1993, 23:95-104.
27. Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, et al.: Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterologe 1995, 108:417-422.
28. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F: Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Mineral Res 1995, 10:250-256.
29. Silvennoinen JA, Karttunen TJ, Niemelä SE, Manelius JJ, Lehtola JK: A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995, 37:71-76.
30. Cowan FJ, Warner JT, Dunstan FDJ, Evans WD, Gregory JW, Jenkins HR: Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child 1997, 76:325-329.
31. Floren CH, Ahren B, Bengtsson M, Bartosik J, Obrant K: Bone mineral density in patients with Crohn's disease during long-term treatment with azathioprine. J Intern Med 1998, 243:123-126.
32. Croucher PI, Vedi S, Motley RJ, Garrahan NJ, Stanton MR, Compston JE: Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporos Int 1993, 3:236-241.
33. Silvennoinen J, Risteli L, Kartunen T, Risteli J: Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut 1996, 38:223-228.
34. Robinson RJ, Iqbal SJ, Abrams K, Al-Azzawi F, Mayberry JF: Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther 1998, 12:699-705.
35. Hyams JS, Wyzga N, Kreutzer DL, Justinich CJ, Granowicz GA: Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. J Pediatr Gastroenterol Nutr 1997, 24:289-295.
36. Fries W, Giacomin D, Plebani M, Martin A: Effect of experimental colitis on bone metabolism in the rat. Digestion 1994, 55:229-233.
37. Lin C-L, Moniz C, Chambers TJ, Chow JWM: Colitis causes bone toss in rats through suppression of bone formation. Gastroenterology 1996, 111:1263-1271.
38. Koniaris SG, Fisher SE, Rubin CT, Chawla A: Experimental colitis impairs linear bone growth independent of nutritional factors. J Pediatr Gastroenterol Nutr 1997, 25:137-141.
39. Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilevitz D: Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998, 93:1483-1490.
40. Valentine JF, Sninsky CA: Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. Am J Gastroenterol 1999, 94:878-883. These guidelines are an adaptation of the recommendations of the American College of Rheumatology for the prevention and treatment of corticosteroid-induced osteoporosis. This is a good review article of the risk factors for bone loss in patients with IBD.
41. Mellström D, Johansson C, Johnell O, Lindstedt G, Lundberg P-A, Obrant K, et al.: Osteoporosis, metabolic aberrations, and increased risk for vertebral fractures after partial gastrectomy. Calcif Tissue Int 1993, 53:370-377.
42. Rümenapf G, Schwille PO, Erben RG, Schreiber M, Berge B, Fries W, et al.: Gastric fundectomy in the rat: effects on mineral and bone metabolism, with emphasis on the gastrin-calcitonin-parathyroid hormone-vitamin D axis. Calcif Tissue Int 1998, 63:433-441.
43. 2-receptor antagonist, Calcif Tissue Int 1998, 62:283-285.
44. Mühlbauer RC, Schenk RK, Chen D, Lehto-Axtelius D, Hakanson R: Morphometric analysis of gastrectomy-evoked osteopenia, Calcif Tissue Int 1998, 62:323-326.
45. Isaia G, Di Stefano M, Roggia C, Ardissone P, Rosina F: Bone disorders in cholestatic liver diseases. Forum 1998, 8:28-38.
46. Argao EA, Specker BL, Heubi JE: Bone mineral content in infants and children with chronic cholestatic liver disease. Pediatrics 1993, 91:1151-1154.
47. Heubi JE, Hollis BW, Specker B, Tsang RC: Bone disease in chronic childhood cholestasis: I: Vitamin D absorption and metabolism. Hepatology 1989, 9:258-264.
48. Argao EA, Heubi JE, Hollis BW, Tsang RC: d-Alpha-tocopheryl polyethylene glycol-1000 succinate enhances the absorption of vitamin D in chronic cholestatic liver disease of infancy and childhood. Pediatr Res 1992, 31:146-150.
49. Bucuvalas JC, Heubi JE, Specker BL, Gregg DJ, Yergey AL, Vieira NE: Calcium absorption in bone disease associated with chronic cholestasis during childhood. Hepatology 1990, 12:1200-1205.
50. Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL: Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985, 103:855-860.
51. Stellon AJ, Webb A, Compston J, Williams R: Low bone turnover state in primary biliary cirrhosis. Hepatology 1987, 7:137-142.
52. Heubi JE, Higgins JV, Argao EA, Sierra RI, Specker BL: The role of magnesium in the pathogenesis of bone disease in childhood cholestatic liver disease. J Pediatr Gastroenterol Nutr 1997, 25:301-306.
53. Guaňabens N, Pares A, Alvarez L, De Osaba MM Monegal A, Peris P, et al.: Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis. J Bone Miner Res 1998, 13:731-738.
54. Houbi JE, Hollis BW, Tsang RC: Bone disease in chronic childhood cholostasis: II: better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia. Podiatr Res 1990, 27:26-31.
55. Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER: Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 1995, 21:389-392.
56. Eastell R, Dickson ER, Hodgson SF, Wiesner RH, Porayko MK, Wahner HW, et al.: Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991, 14:296-300.
57. Hill SA, Kelly DA, John PR: Bone fractures in children undergoing orthotopic liver transplantation. Pediatr Radiol 1995, 25 (suppl 1):112-117.
58. Argao EA, Balistreri WF, Mollis BW, Ryckman FC, Heubi JE: Effect of orthotopic liver transplantation on bone mineral content and serum vitamin D metabolites in infants and children with chronic cholestasis. Hepatotogy 1994, 20:598-603.
59. Reeves HL, Francis RM, Manas DM, Hudson M, Day CP: Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation. Liver Transpl Surg 1998, 4:404-409.
60. Reich D, Rothstein K, Manzarbeitia C, Munoz S: Common medical diseases after liver transplantation. Semin Gastrointest Dis 1998, 9:110-125.
61. Khosla S, Hassoun AA, Baker BK, Liu F, Zein NN, Whyte MP, et al.: Insulinlike growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults. J Clin Invest 1998, 101:2165-2179.